{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:42:46Z","timestamp":1760784166987},"reference-count":22,"publisher":"Elsevier BV","issue":"51","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.vaccine.2016.06.041","type":"journal-article","created":{"date-parts":[[2016,8,24]],"date-time":"2016-08-24T10:12:43Z","timestamp":1472033563000},"page":"6512-6517","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Cross-species prediction of human survival probabilities for accelerated anthrax vaccine absorbed (AVA) regimens and the potential for vaccine and antibiotic dose sparing"],"prefix":"10.1016","volume":"34","author":[{"given":"G.V.","family":"Stark","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.S.","family":"Sivko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"VanRaden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Schiffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.L.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.A.","family":"Hewitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.P.","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.O.","family":"Nuzum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.06.041_b0005","unstructured":"FDA Approval Letter \u2013 BioThrax. <http:\/\/www.fda.gov\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/ucm304758.htm>."},{"key":"10.1016\/j.vaccine.2016.06.041_b0010","unstructured":"FDA (2012) BoThrax\u00ae-Package Insert. <http:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/BloodBloodProducts\/ApprovedProducts\/LicensedProductsBLAs\/UCM074923.pdf>."},{"issue":"8","key":"10.1016\/j.vaccine.2016.06.041_b0015","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.vaccine.2013.10.039","article-title":"Effect of reduced dose schedules and intramuscular injection of anthrax vaccine adsorbed on immunological response and safety profile: a randomized trial","volume":"32","author":"Wright","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.06.041_b0020","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1128\/CVI.00324-12","article-title":"A three-dose intramuscular injection schedule of anthrax vaccine adsorbed generates sustained humoral and cellular immune responses to protective antigen and provides long-term protection against inhalation anthrax in rhesus macaques","volume":"19","author":"Quinn","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2016.06.041_b0025","unstructured":"November 16-17, 2010: Vaccines and related biological products advisory committee meeting presentations. <http:\/\/www.fda.gov\/AdvisoryCommittees\/CommitteesMeetingMaterials\/BloodVaccinesandOtherBiologics\/VaccinesandRelatedBiologicalProductsAdvisoryCommittee\/ucm239733.htm>."},{"issue":"7","key":"10.1016\/j.vaccine.2016.06.041_b0030","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1128\/CVI.00099-13","article-title":"Evaluation of immunogenicity and efficacy of anthrax vaccine adsorbed for post-exposure prophylaxis","volume":"20","author":"Ionin","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2016.06.041_b0035","unstructured":"2014 Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Strategy and Implementation Plan. <http:\/\/www.phe.gov\/Preparedness\/mcm\/phemce\/Documents\/2014-phemce-sip.pdf>."},{"issue":"47","key":"10.1016\/j.vaccine.2016.06.041_b0040","doi-asserted-by":"crossref","first-page":"6284","DOI":"10.1016\/j.vaccine.2014.08.076","article-title":"Immunogenicity and safety of four different dosing regimens of anthrax vaccine adsorbed for post-exposure prophylaxis for anthrax in adults","volume":"32","author":"Bernstein","year":"2014","journal-title":"Vaccine"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2016.06.041_b0045","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.vaccine.2003.07.004","article-title":"Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine","volume":"22","author":"Little","year":"2004","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2016.06.041_b0050","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1128\/IAI.01289-12","article-title":"Pathology and pathophysiology of inhalational anthrax in a guinea pig model","volume":"81","author":"Savransky","year":"2013","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.06.041_b0055","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1016\/S0264-410X(01)00234-1","article-title":"In vitro correlate of immunity in a rabbit model of inhalational anthrax","volume":"19","author":"Pitt","year":"2001","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2016.06.041_b0060","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1128\/CVI.00469-14","article-title":"Comprehensive analysis and selection of anthrax vaccine adsorbed immune correlates of protection in rhesus macaques","volume":"21","author":"Chen","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2016.06.041_b0065","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004073","article-title":"Anthrax vaccine\u2013induced antibodies provide cross-species prediction of survival to aerosol challenge","volume":"4","author":"Fay","year":"2012","journal-title":"Sci Transl Med"},{"issue":"31","key":"10.1016\/j.vaccine.2016.06.041_b0070","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1016\/j.vaccine.2015.05.091","article-title":"Bridging non-human primate correlates of protection to reassess the Anthrax Vaccine Adsorbed booster schedule in humans","volume":"33","author":"Schiffer","year":"2015","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2016.06.041_b0075","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/nbt1007-1084","article-title":"The FDA animal efficacy rule and biodefense","volume":"25","author":"Gronval","year":"2007","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.vaccine.2016.06.041_b0085","doi-asserted-by":"crossref","first-page":"6518","DOI":"10.1016\/j.vaccine.2016.04.048","article-title":"Evaluation of early immune response-survival relationship in cynomolgus macaques after Anthrax Vaccine Absorbed vaccination and Bacillus anthracis spore challenge","volume":"34","author":"Sivko","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.06.041_b0090","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1016\/j.vaccine.2008.04.016","article-title":"Prediction of pertussis vaccine efficacy using a correlates of protection model","volume":"26","author":"Kohberger","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.06.041_b0095","series-title":"An introduction to the bootstrap","author":"Efron","year":"1993"},{"key":"10.1016\/j.vaccine.2016.06.041_b0100","first-page":"205","article-title":"Welch\u2019s approximate solution for the Behren\u2019s-Fisher problem","volume":"29","author":"Best","year":"1987","journal-title":"Technometrics"},{"key":"10.1016\/j.vaccine.2016.06.041_b0105","unstructured":"SAS Copyright, SAS Institute Inc. SAS and all other SAS Institute Inc. product or service names are registered trademarks or trademarks of SAS Institute Inc., Cary, NC, USA."},{"key":"10.1016\/j.vaccine.2016.06.041_b0110","series-title":"R: A language and environment for statistical computing","author":"R Core Team","year":"2015"},{"key":"10.1016\/j.vaccine.2016.06.041_b0115","unstructured":"http:\/\/www.fda.gov\/BiologicsBloodVaccines\/Vaccines\/ucm061751.htm."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16304650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16304650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,9]],"date-time":"2018-09-09T01:57:40Z","timestamp":1536458260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16304650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":22,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0264410X16304650"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.06.041","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cross-species prediction of human survival probabilities for accelerated anthrax vaccine absorbed (AVA) regimens and the potential for vaccine and antibiotic dose sparing","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.06.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}